Overview

Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)

Status:
Completed
Trial end date:
2012-08-14
Target enrollment:
Participant gender:
Summary
This study will explore the dose-response of losartan as well as the safety and tolerability in children from 6 months to 6 years of age.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Losartan